Sunday, 20 September 2026European Markets

Barbara Bu

Loading stream...

about barbara bui

barbara bui sa is an established french fashion label specializing in ready-to-wear clothing and accessories for women since 1982. established as a supplier through wholesale distributors and stores worldwide, barbara bui sa's extensive catalog includes coats, jackets, tops and shirts (t-shirts), mesh pants/dresses/skirts (leather products/tailored cloth), shoes bags scarves belts etc - with its products accessible through wholesale distributors, online and offline stores alike based out of paris itself. thanks to its commitment to fashion and quality it has earned itself an esteemed place within stylish women worldwide. headquartered out of paris france since 1982, barbara bui sa has earned itself an esteemed place within their market of specialty.

quarter analysis

this data indicates that revenue has grown 10.6% year-on-year to 11.45m for its twelve month revenue total. this indicates growth in its revenue stream, which should be encouraging to investors; however, other aspects such as expenses and profitability must also be taken into consideration when assessing a company's overall financial health and potential growth potential.

equity analysis

as investment professionals, let us explore barbara bui's financial data as an expert investment analyst would. pay special attention to their dividend yield, earnings per share (eps), price-earnings ratio (pe ratio), and return on equity (roe). dividend yield the current dividend yield stands at 4.08% and provides potential investors with information regarding annual dividend payments relative to stock price. using this data, potential investors can determine their return on investment from investments made using this method. earnings per share barbara bui's trailing twelve month earnings per share (eps) stands at eur1.04. this represents its profit per outstanding share, and higher epss usually indicate more profitable companies, potentially leading to higher stock prices and greater returns for investors. barbara bui has an 8.27 trailing 12-month pe ratio, meaning investors are paying eur8.27 for every euro of annual earnings. a lower pe ratio may suggest undervaluation; this could make barbara bui an appealing buy, though other factors should also be taken into consideration when making decisions about investments. return on equity our firm currently enjoys a return on equity ratio of 125.51% for the trailing twelve months, which indicates that for every euro of shareholder equity invested, the company generated eur1.26 in profit. such an efficiency in using its equity to generate returns could be seen as positive indication of potential investor interest in our firm. overall, barbara bui's financial data presents a reasonable dividend yield, an acceptable pe ratio, and a robust roe that should be taken into consideration by potential investors when selecting it for their portfolios. but before making any definitive investment decisions based on this analysis alone it's essential that further research be performed with regards to industry trends, competitive landscape and other relevant aspects being taken into consideration. more news about barbara bui (bui.pa).
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com